2018 Q3 Form 10-Q Financial Statement

#000164033418002167 Filed on November 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $78.00 $934.00
YoY Change -91.65% 132.34%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $40.00K $160.0K
YoY Change -75.0% 433.33%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.500K $10.81K
YoY Change -39.86% -2.57%
% of Gross Profit
Operating Expenses $44.32K $172.9K
YoY Change -74.36% 311.18%
Operating Profit -$44.24K -$171.9K
YoY Change -74.27% 312.91%
Interest Expense -$42.58K $100.5K
YoY Change -142.38%
% of Operating Profit
Other Income/Expense, Net -$173.3K -$234.7K
YoY Change -26.14% 10675.62%
Pretax Income -$220.0K -$410.0K
YoY Change -46.34% 925.0%
Income Tax
% Of Pretax Income
Net Earnings -$217.6K -$406.6K
YoY Change -46.49% 827.98%
Net Earnings / Revenue -278943.59% -43536.72%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.04 -$0.12
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.00K $0.00
YoY Change -100.0%
Cash & Equivalents $22.69K $548.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $22.69K $548.00
YoY Change 4040.33% -94.52%
LONG-TERM ASSETS
Property, Plant & Equipment $800.00 $28.24K
YoY Change -97.17% -60.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $800.00 $28.24K
YoY Change -97.17% -60.54%
TOTAL ASSETS
Total Short-Term Assets $22.69K $548.00
Total Long-Term Assets $800.00 $28.24K
Total Assets $23.49K $28.78K
YoY Change -18.4% -64.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $270.0K $100.0K
YoY Change 170.0% 4077.11%
Accrued Expenses $250.0K $150.0K
YoY Change 66.67% 150.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $340.0K $140.0K
YoY Change 142.86%
Total Short-Term Liabilities $2.091M $644.0K
YoY Change 224.65% 930.72%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.091M $644.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $2.091M $644.0K
YoY Change 224.65% 930.72%
SHAREHOLDERS EQUITY
Retained Earnings -$6.995M -$5.189M
YoY Change 34.79% 25.76%
Common Stock $124.0K $72.51K
YoY Change 71.08% 56.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.067M -$615.2K
YoY Change
Total Liabilities & Shareholders Equity $23.49K $28.78K
YoY Change -18.4% -64.71%

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$217.6K -$406.6K
YoY Change -46.49% 827.98%
Depreciation, Depletion And Amortization $6.500K $10.81K
YoY Change -39.86% -2.57%
Cash From Operating Activities -$24.58K -$43.87K
YoY Change -43.96% 338.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $200.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $77.00 $1.850K
YoY Change -95.84%
NET CHANGE
Cash From Operating Activities -$24.58K -$43.87K
Cash From Investing Activities 0.000
Cash From Financing Activities $77.00 $1.850K
Net Change In Cash -$24.51K -$42.02K
YoY Change -41.68% 320.19%
FREE CASH FLOW
Cash From Operating Activities -$24.58K -$43.87K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 dei Entity Registrant Name
EntityRegistrantName
APPYEA, INC
CY2018Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001568969
CY2018Q3 dei Trading Symbol
TradingSymbol
apyp
CY2018Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2018Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1267789860 shares
CY2018Q3 dei Document Type
DocumentType
10-Q
CY2018Q3 dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
CY2018Q3 dei Amendment Flag
AmendmentFlag
false
CY2018Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2018Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47196 usd
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22689 usd
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42567 usd
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
548 usd
CY2018Q2 us-gaap Assets Current
AssetsCurrent
47196 usd
CY2018Q3 us-gaap Assets Current
AssetsCurrent
22689 usd
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7300 usd
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
800 usd
CY2018Q2 us-gaap Assets
Assets
54496 usd
CY2018Q3 us-gaap Assets
Assets
23489 usd
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
275312 usd
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
266943 usd
CY2018Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
224000 usd
CY2018Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
248000 usd
CY2018Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
290823 usd
CY2018Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
332887 usd
CY2018Q2 apyp Convertible Debt Related Party
ConvertibleDebtRelatedParty
8977 usd
CY2018Q3 apyp Convertible Debt Related Party
ConvertibleDebtRelatedParty
9488 usd
CY2018Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
88087 usd
CY2018Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
85689 usd
CY2018Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1016865 usd
CY2018Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1147626 usd
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1904064 usd
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2090633 usd
CY2018Q2 us-gaap Liabilities
Liabilities
1904064 usd
CY2018Q3 us-gaap Liabilities
Liabilities
2090633 usd
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
124047 usd
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
124047 usd
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4740277 usd
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4740277 usd
CY2018Q2 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
62727 usd
CY2018Q3 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
62727 usd
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6777119 usd
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6994695 usd
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-1849568 usd
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-2067144 usd
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54496 usd
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23489 usd
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
250570 usd
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
257070 usd
CY2018Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
81968 usd
CY2018Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
56994 usd
CY2018Q2 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2018Q3 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1240477060 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1240477060 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1240477060 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1240477060 shares
CY2017Q3 us-gaap Revenues
Revenues
934 usd
CY2018Q3 us-gaap Revenues
Revenues
78 usd
CY2017Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
934 usd
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78 usd
CY2017Q3 us-gaap Professional Fees
ProfessionalFees
64830 usd
CY2018Q3 us-gaap Professional Fees
ProfessionalFees
9561 usd
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
97236 usd
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28257 usd
CY2017Q3 us-gaap Depreciation
Depreciation
10808 usd
CY2018Q3 us-gaap Depreciation
Depreciation
6500 usd
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
172874 usd
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
44318 usd
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-171940 usd
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44240 usd
CY2017Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-134237 usd
CY2018Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-130761 usd
CY2017Q3 us-gaap Interest Expense
InterestExpense
100456 usd
CY2018Q3 us-gaap Interest Expense
InterestExpense
42575 usd
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-234693 usd
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-173336 usd
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-406633 usd
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-217576 usd
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
664499399 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1240477060 shares
CY2017Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
81813 usd
CY2018Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24974 usd
CY2017Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
93263 usd
CY2018Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8369 usd
CY2017Q3 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
24000 usd
CY2018Q3 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
24000 usd
CY2017Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18643 usd
CY2018Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
17601 usd
CY2017Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43869 usd
CY2018Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22109 usd
CY2017Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200 usd
CY2018Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
142167 usd
CY2018 apyp Proceeds From Convertible Notes Payable Related Party Net Of Original Issue Discounts
ProceedsFromConvertibleNotesPayableRelatedPartyNetOfOriginalIssueDiscounts
8333 usd
CY2017Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1750 usd
CY2018Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4196 usd
CY2017Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
100 usd
CY2018Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
6594 usd
CY2017Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1850 usd
CY2018Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2398 usd
CY2017Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-42019 usd
CY2018Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-24507 usd
CY2017Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2018Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2017Q3 apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
69284 usd
CY2017Q3 us-gaap Notes Reduction
NotesReduction
137170 usd
CY2017Q3 apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
67500 usd
CY2018Q3 us-gaap Nature Of Operations
NatureOfOperations
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>1. NATURE OF OPERATIONS</b></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company incorporated a wholly-owned subsidiary, &#8220;AppYea Holdings, Inc.&#8221; in state of South Dakota on January 13, 2017 and "The Diagnostic Centers Inc." in State of South Dakota on August 2, 2017.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Through its wholly owned subsidiary, The Diagnostic Centers, Inc., AppYea markets comprehensive diagnostic testing services to physician offices, clinics, hospitals, long term care facilities, healthcare groups, and other healthcare providers.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company's common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol "APYP". The first day of trading on the OTC Markets was December 15, 2014.</p>
CY2018Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
644 usd
CY2018Q3 us-gaap Use Of Estimates
UseOfEstimates
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Use of Estimates</b></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets.</p>
CY2018Q2 us-gaap Notes Payable
NotesPayable
8333 usd
CY2018Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1155 usd
CY2018Q2 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
8977 usd
CY2018Q3 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
9488 usd
CY2018Q3 us-gaap Notes Payable
NotesPayable
8333 usd
CY2018Q3 apyp Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
2067944 usd
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345614 usd
CY2018Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345614 usd
CY2018Q2 us-gaap Interest Payable Current
InterestPayableCurrent
27177 usd
CY2018Q3 us-gaap Interest Payable Current
InterestPayableCurrent
44267 usd
CY2018Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
290823 usd
CY2018Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
332887 usd
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
290823 usd
CY2018Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
332887 usd
CY2018Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2018Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
592916818 shares
CY2018Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
592916818 shares
CY2018Q3 apyp Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
0 shares
CY2018Q3 apyp Class Of Warrant Or Right With Reset Feature
ClassOfWarrantOrRightWithResetFeature
0 shares
CY2018Q3 apyp Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
CY2018Q3 apyp Class Of Warrant Or Right Forfeited Or Cancellation
ClassOfWarrantOrRightForfeitedOrCancellation
0 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0004
CY2018Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0004
CY2018Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price Granted
ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
0
CY2018Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price With Reset Feature
ClassOfWarrantOrRightWeightedAverageExercisePriceWithResetFeature
0
CY2018Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
0
CY2018Q3 apyp Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Canceled
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrCanceled
0
CY2017Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
81813 usd
CY2018Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
24974 usd
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
78947 usd
CY2018Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05 pure
CY2018Q2 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
20 day
CY2018Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0002
CY2018Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
27312800 shares
CY2018 us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M
CY2018Q2 apyp Class Of Warrant Or Right Exercisable Of Common Stock Shares
ClassOfWarrantOrRightExercisableOfCommonStockShares
394735000 shares
CY2018Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
8333 usd
CY2018Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
8333 usd
CY2018Q2 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2018Q3 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2018 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2018 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.45 pure
CY2018Q2 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
965401 usd
CY2018Q3 apyp Value Assigned To Derivative Liability Recognized As Debt Discount
ValueAssignedToDerivativeLiabilityRecognizedAsDebtDiscount
8333 usd
CY2018Q3 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
688234 usd
CY2018Q3 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
130761 usd
CY2018Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000000 shares
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200 usd
CY2017Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
613 usd
CY2018Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
623 usd
CY2013Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3M
CY2013Q1 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
Three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term.
CY2018Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1500 shares
CY2018Q3 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
voting rights of 1,000 shares of common stock.
CY2018Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200 usd
CY2018Q3 apyp Stock Issued Period For Common Stock Payable
StockIssuedPeriodForCommonStockPayable
57273 usd
CY2018Q2 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
55000000 shares
CY2018Q3 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
25000000 shares
CY2018Q2 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
105000 usd
CY2018Q3 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
47727 usd
CY2018Q3 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
2185 usd
CY2018Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q3 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
116666 usd
CY2018Q2 apyp Additional Class Of Warrant Or Right Number Of Securities Called By Warrants
AdditionalClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrants
394735000 shares
CY2018Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2017Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd

Files In Submission

Name View Source Status
0001640334-18-002167-index-headers.html Edgar Link pending
0001640334-18-002167-index.html Edgar Link pending
0001640334-18-002167.txt Edgar Link pending
0001640334-18-002167-xbrl.zip Edgar Link pending
apyp-20180930.xsd Edgar Link pending
apyp_10q.htm Edgar Link pending
apyp_ex311.htm Edgar Link pending
apyp_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
apyp-20180930.xml Edgar Link completed
apyp-20180930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apyp-20180930_lab.xml Edgar Link unprocessable
apyp-20180930_pre.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apyp-20180930_def.xml Edgar Link unprocessable